Compare HLSQ & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLSQ | XXII |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 972.0K | 949.6K |
| IPO Year | 2018 | 2011 |
| Metric | HLSQ | XXII |
|---|---|---|
| Price | $0.28 | $0.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 191.6K |
| Earning Date | 11-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 560.42 | 69.96 |
| EPS | ★ 3.56 | N/A |
| Revenue | N/A | ★ $25,832,530.00 |
| Revenue This Year | N/A | $361.06 |
| Revenue Next Year | N/A | $1,493.14 |
| P/E Ratio | $0.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.23 | $0.27 |
| 52 Week High | $0.77 | $11.37 |
| Indicator | HLSQ | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 10.69 | 22.29 |
| Support Level | N/A | $0.51 |
| Resistance Level | $0.45 | $0.99 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 8.91 | 2.36 |
Tessera Defense and Homeland Security Inc develops and acquires technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response markets - building a portfolio around the growing need for earlier, more accurate threat detection as UAVs and other autonomous systems reshape the operating environment. The Company's portfolio includes Zorronet, an AI-powered autonomous command-and-control platform, and DFSL, a developer of LADAR-based counter-UAS and perimeter security systems.
22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.